Advertisement

Topics

BioCryst nets $75mm via FOPO

15:40 EDT 14 Sep 2017 | Elsevier Business Intelligence

BioCryst Pharmaceuticals Inc. netted $75mm through the follow-on public offering of 15.5mm common shares at $5.15 each. The c...

Original Article: BioCryst nets $75mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "BioCryst nets $75mm via FOPO"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...